BCGP Pharmacists: In order for BCGP courses to post to the BPS Portal, your ASCP profile must be updated with your BCGP Credential Number (NOT the BPS-IND#) and email address registered with BPS. **Email address must be identical in both accounts.

Date:This live activity took place on October 11, 2018 from 1:00 – 2:00 pm ET. Participants who attended the live activity cannot receive credit for this home-study version.

*This home study version was released on November 1, 2018. Per BPS, all BCGP Recertification courses can only be published for 6 months.

Cost: Free for ASCP Members, $29 for Non-Members. **In celebrate of Senior Care Pharmacist Week last month, we are offering this BCGP on-demand version free of charge to ASCP members.

*If you are looking for CPE registration, please click here*

Speaker:
Tessa Rife, PharmD, BCGP, CACP
Academic Detailing Program Manager; Clinical Pharmacy Specialist, Addiction Consult and Prescription Opioid Safety Team; Clinical Assistant Professor, UCSF School of Pharmacy
San Francisco Veterans Affairs Health Care System

Financial Disclosure:
The speaker discloses no relevant financial conflicts of interest with regard to this activity.

Target Audience:
This session will be delivered by a clinical pharmacy specialist on an Addiction Consult, Prescription Opioid Safety, and Benzodiazepine Taper Team. Participants managing older adults prescribed benzodiazepines seeking to improve safety in this vulnerable population may benefit from attending this session. Using a case-based approach, the presenter will discuss the prevalence and risks associated with benzodiazepine use in older adults and other special populations, examine the evidence and clinical care models for safe and effective tapering, discuss non-benzodiazepine alternatives, review techniques to assess willingness and motivation to taper, and offer strategies to design individualized and supported benzodiazepine taper care plans.

Learning Objectives:
At the conclusion of this application-based activity, participants should be able to:

• Describe the prevalence of benzodiazepine use and risks associated with adverse outcomes in older adults and other special populations
• Review the evidence and patient care models for safe and effective benzodiazepine tapers
• Discuss non-pharmacologic and pharmacologic alternatives to benzodiazepines
• Utilize the Ask-Tell-Ask approach and motivational interviewing techniques to assess patient willingness to taper benzodiazepines
• Design an individualized and supported benzodiazepine taper care plan

Continuing Pharmacy Education:
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
UAN: 0203-0000-18-051-H01-P
Credits: 1.5 Contact Hours (1 hour of recorded content, 0.5 hours for post-test assessment)
Expiration: December 11, 2021 by 11:59 pm ET

*This course will expire May 1, 2019 at 11:59 pm ET. No exceptions or extensions permitted. *

How to Earn Credit:
BCGP Credit: Per the Board of Pharmacy Specialties (BPS), all pharmacists seeking BCGP Recertification have ONE attempt to achieve a 70% or higher on the 10-question post-test.

CPE Credit: You must complete the post-test and evaluation by May 1, 2019 at 11:59 pm ET to receive credit. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.

Please see computer hardware/software requirements here.